Somatostatin receptor expression, tumour response, and quality of life in patients with advanced hepatocellular carcinoma treated with long-acting octreotide

Por Cebon, J
Publicado em 2006

Dose-intense weekly cyclophosphamide, methotrexate, 5-fluorouracil, vincristine and prednisolone (CMFP) in advanced breast cancer.

Por Cebon, J. S., Bishop, J. F., Harvey, V., Mason, B., Jeal, P. N.
Publicado em 1990

Interleukin-4 suppresses granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor levels in stimulated human monocytes.

Por Hamilton, J A, Whitty, G A, Royston, A K, Cebon, J, Layton, J E
Publicado em 1992

Differential alterations in plasma colony-stimulating factor concentrations in meningococcaemia.

Por Waring, P M, Presneill, J, Maher, D W, Layton, J E, Cebon, J, Waring, L J, Metcalf, D
Publicado em 1995

Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology.

Por Stanley, E, Lieschke, G J, Grail, D, Metcalf, D, Hodgson, G, Gall, J A, Maher, D W, Cebon, J, Sinickas, V, Dunn, A R
Publicado em 1994

Cancer testis antigens expression in mesothelioma: role of DNA methylation and bioimmunotherapeutic implications

Por Sigalotti, L, Coral, S, Altomonte, M, Natali, L, Gaudino, G, Cacciotti, P, Libener, R, Colizzi, F, Vianale, G, Martini, F, Tognon, M, Jungbluth, A, Cebon, J, Maraskovsky, E, Mutti, L, Maio, M
Publicado em 2002

Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy

Por Bowyer, S, Prithviraj, P, Lorigan, P, Larkin, J, McArthur, G, Atkinson, V, Millward, M, Khou, M, Diem, S, Ramanujam, S, Kong, B, Liniker, E, Guminski, A, Parente, P, Andrews, M C, Parakh, S, Cebon, J, Long, G V, Carlino, M S, Klein, O
Publicado no Br J Cancer (2016)

Multiplex immunohistochemistry accurately defines the immune context of metastatic melanoma

Por Halse, H., Colebatch, A. J., Petrone, P., Henderson, M. A., Mills, J. K., Snow, H., Westwood, J. A., Sandhu, S., Raleigh, J. M., Behren, A., Cebon, J., Darcy, P. K., Kershaw, M. H., McArthur, G. A., Gyorki, D. E., Neeson, P. J.
Publicado no Sci Rep (2018)

Somatostatin receptor expression, tumour response and quality of life in patients with advanced hepatocellular carcinoma treated with long-acting octreotide

Por Cebon, J, Findlay, M, Hargreaves, C, Stockler, M, Thompson, P, Boyer, M, Roberts, S, Poon, A, Scott, A M, Kalff, V, Garas, G, Dowling, A, Crawford, D, Ring, J, Basser, R, Strickland, A, Macdonald, G, Green, M, Nowak, A, Dickman, B, Dhillon, H, Gebski, V
Publicado em 2007

Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma

Por Wolchok, J.D., Chiarion-Sileni, V., Gonzalez, R., Rutkowski, P., Grob, J.-J., Cowey, C.L., Lao, C.D., Wagstaff, J., Schadendorf, D., Ferrucci, P.F., Smylie, M., Dummer, R., Hill, A., Hogg, D., Haanen, J., Carlino, M.S., Bechter, O., Maio, M., Marquez-Rodas, I., Guidoboni, M., McArthur, G., Lebbé, C., Ascierto, P.A., Long, G.V., Cebon, J., Sosman, J., Postow, M.A., Callahan, M.K., Walker, D., Rollin, L., Bhore, R., Hodi, F.S., Larkin, J.
Publicado no N Engl J Med (2017)